May 22, 2025   SOURCE: PR NewsWire

Golden Helix Launches Enterprise Genomic Analysis with VarSeq 3 and VSWarehouse 3

BOZEMAN, Mont., May 22, 2025 /PRNewswire/ -- Golden Helix today announced the release of VarSeq 3 and VSWarehouse 3, marking a major milestone in enterprise-scale secondary and tertiary genomic analysis. The release introduces cloud-native deployment options optimized for AWS and Azure, expanded support for hybrid and on-premise support, flexible licensing models including per-sample packaging tailored to small and mid-sized labs. To support these new deployment and licensing models, the release includes seamless integration of secondary analysis and expanded capabilities for long-read sequencing, including accurate detection and interpretation of repeat expansions.

These new capabilities make Golden Helix's integrated platform ideal for high-throughput labs, national genome initiatives, and smaller diagnostic labs alike, delivering unmatched scalability, automation, and deployment flexibility.

"With VarSeq 3 and its integration into VSWarehouse 3, we are equipping our customers with the infrastructure readiness and data ownership they need to operate at scale--whether in private cloud, hybrid, or fully cloud-native settings," said Dr. Andreas Scherer, President and CEO of Golden Helix. "This release also expands access to our enterprise-grade platform through per-sample licensing, helping smaller and growing labs take advantage of our full suite of features as they scale."

Key Highlights of VarSeq 3 and VSWarehouse 3:

    --  Cloud-Optimized, Hybrid-Ready Deployments Customer can deploy on AWS,
        Azure, or their own private infrastructure with full support for hybrid
        environments. The architecture supports elastic compute provisioning,
        seamless updates, and integration with cloud-native storage solutions.
        Workloads scale dynamically based on demand, whether running on-prem, in
        the cloud, or across distributed clusters--always under full customer
        data control.

    --  Secure Collaboration & Data FederationEnable national-level genome data
        coordination and multi-site collaboration via fine-grained access
        control and secure data sharing. Native integrations with cloud object
        storage and third-party NGS repositories streamline cloud-to-cloud data
        transfer and federated analysis across institutions and geographies.

    --  Per-Sample Licensing OptionsFor the first time, Golden Helix introduces
        per-sample packages that give smaller labs and those with seasonal or
        variable sample volumes access to enterprise capabilities, without the
        upfront cost of unlimited sample licenses.

    --  Integration for Secondary AnalysisUnified integration layer for
        secondary analysis, allowing labs to seamlessly connect upstream
        pipelines with clinical interpretation workflows. Variant calls,
        alignment metrics, and quality control outputs from various tools can
        now be automatically ingested, stored, and analyzed in a single
        environment.

    --  Comprehensive Genomic Workflow AutomationAutomate full pipelines across
        clinical domains including pharmacogenomics, carrier screening, CNV, and
        repeat expansion analysis. Built-in auto-classification and expert
        curated annotations reduce interpretation time and support regulatory
        compliance.

    --  Long-Read Genomics SupportThis release deepens Golden Helix's support
        for long-read sequencing technologies, including repeat expansion
        detection critical for diagnosing rare disorders like Huntington's
        disease and Fragile X. These capabilities extend across both secondary
        and tertiary workflows.

Golden Helix will present VarSeq 3 and VSWarehouse 3 at the upcoming European Society of Human Genetics (ESHG) conference, taking place May 24-26, 2025 in Milan, Italy. Attendees are invited to visit Booth 510 for live demonstrations and to engage with the Golden Helix team on the future of enterprise-scale genomic analysis.

For more information or to request a demo, visit: www.goldenhelix.com

About Golden Helix

Golden Helix has delivered trusted bioinformatics solutions for over 25 years to hospitals, testing labs, research institutions, and national genome programs around the world. With powerful tools for tertiary analysis and genomic warehousing, Golden Helix empowers customers to uncover disease-causing mutations, personalize treatment decisions, and accelerate discoveries in rare diseases and oncology.

Casey Fullem
Director of Marketing
Golden Helix, Inc.
(406) 551-4901
fullem@goldenhelix.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/golden-helix-launches-enterprise-genomic-analysis-with-varseq-3-and-vswarehouse-3-302462110.html

SOURCE Golden Helix Inc